In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii
- 1 July 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (7), 1530-1537
- https://doi.org/10.1128/aac.39.7.1530
Abstract
In order to characterize the delayed effect of clindamycin and macrolide antibiotics against Toxoplasma gondii tachyzoites (E. R. Pfefferkorn and S. E. Borotz, Antimicrob. Agents Chemother. 38:31-37, 1994), we have carefully examined the replication of parasites as a function of time after drug addition. Intracellular tachyzoites treated with up to 20 microM clindamycin (> 1,000 times the 50% inhibitory concentration) exhibit doubling times indistinguishable from those of controls (approximately 7 h). Drug-treated parasites emerge from infected cells and establish parasitophorous vacuoles inside new host cells as efficiently as untreated controls, but replication within the second vacuole is dramatically slowed. Growth inhibition in the second vacuole does not require continued presence of drug, but it is dependent solely on the concentration and duration of drug treatment in the first (previous) vacuole. The susceptibility of intracellular parasites to nanomolar concentrations of clindamycin contrasts with that of extracellular tachyzoites, which are completely resistant to treatment, even through several cycles of subsequent intracellular replication. This peculiar phenotype, in which drug effects are observed only in the second infectious cycle, also characterizes azithromycin and chloramphenicol treatment, but not treatment with cycloheximide, tetracycline, or anisomycin. These findings provide new insights into the mode of clindamycin and macrolide action against T. gondii, although the relevant target for their action remains unknown.Keywords
This publication has 25 references indexed in Scilit:
- Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.JCI Insight, 1995
- Toxoplasma gondii: Secretion of a Potent Nucleoside Triphosphate Hydrolase into the Parasitophorous VacuoleExperimental Parasitology, 1994
- Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1993
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Have malaria parasites three genomes?Parasitology Today, 1991
- Organisation and expression of small subunit ribosomal RNA genes encoded by a 35-kilobase circular DNA in Plasmodium falciparumMolecular and Biochemical Parasitology, 1991
- Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDSEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosisAIDS, 1991
- Current Recommendations and Future Prospects in the Treatment of ToxoplasmosisDrugs, 1989
- In Vitro Assessment of Antimicrobial Agents Against Toxoplasma gondiiThe Journal of Infectious Diseases, 1988